Core Content edited by

Journal Review

Should All Patients with AMI Get O2?

Filed Under: Tags: , , , November 2nd, 2017 Leave a Comment

Each year approximately 790,000 Americans suffer an acute myocardial infarction (AMI) (Benjamin 2017). Traditional treatment for an acute myocardial infarction has included morphine, oxygen, nitroglycerine and aspirin (MONA) with interventions such as percutaneous coronary intervention providing more definitive management. There has been little data from randomized control studies that supports the use of oxygen in AMI.
Read More

Core

Non-Traumatic Monocular Vision Loss

Filed Under: Tags: , , , , , , , Leave a Comment

This post discusses the major causes of non-traumatic vision loss focusing on ED diagnosis and management.
Read More

Cases

November 2017

Tags: , , , Leave a Comment

Shortness of breath and abdominal pain
Read More

Journal Review

Predicting Dysrhythmia after Syncope

Filed Under: Tags: , , October 26th, 2017 2 Comments

Syncope, the sudden, brief loss of consciousness followed by spontaneous, complete recovery is a common presentation to the Emergency Department (ED). It represents a significant portion of overall admissions to the hospital because while many cases are benign (i.e. vasovagal syncope), some may result from a life-threatening cause (ventricular tachydysrhythmia, myocardial ischemia, gastrointestinal bleeding etc).
Read More

Journal Review

Prospective Validation of the HEART Score

Filed Under: Tags: , , , , , October 19th, 2017 Leave a Comment

Chest pain representing acute coronary syndrome (ACS) is the most common reason patients presenting to the emergency department (ED) are admitted to the hospital. The treatment for ACS is early targeted therapy and missed cases results in increased morbidity and mortality. As a result many clinicians choose to admit patients for further evaluation, resulting in further testing and higher medical costs.
Read More

Core

Hyperglycemic Hyperosmolar Syndrome

Filed Under: Tags: , , One Comment

This post discusses the clinical presentation of HHS and the emergency management that needs to be rapidly applied.
Read More

Journal Review

Safety of PE Treatment with Rivaroxaban

Filed Under: Tags: , , , October 12th, 2017 Leave a Comment

The simplified PE Severity Index (sPESI) is one of several validated prognostic tools for acute pulmonary embolism (PE).  The European Society of Cardiology recommended the use of the sPESI to risk-stratify patients with acute PE into low risk (sPESI=0) and non-low risk (sPESI≥1) in order to guide treatment and disposition (Konstantinides 2014).  Systematic reviews and meta-analyses have found that outpatient management of low-risk PE patients with standard therapy is safe,
Read More